vs
Side-by-side financial comparison of BCB BANCORP INC (BCBP) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.
CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $26.2M, roughly 1.5× BCB BANCORP INC). CODEXIS, INC. runs the higher net margin — 24.7% vs -49.7%, a 74.3% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 13.1%). BCB BANCORP INC produced more free cash flow last quarter ($34.9M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 1.8%).
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
BCBP vs CDXS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.2M | $38.9M |
| Net Profit | $-12.0M | $9.6M |
| Gross Margin | — | 94.8% |
| Operating Margin | -71.9% | 27.1% |
| Net Margin | -49.7% | 24.7% |
| Revenue YoY | 13.1% | 81.3% |
| Net Profit YoY | -467.6% | 192.5% |
| EPS (diluted) | $-0.73 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.2M | $38.9M | ||
| Q3 25 | $26.5M | $8.6M | ||
| Q2 25 | $25.2M | $15.3M | ||
| Q1 25 | $23.8M | $7.5M | ||
| Q4 24 | $23.1M | $21.5M | ||
| Q3 24 | $26.2M | $12.8M | ||
| Q2 24 | $20.4M | $8.0M | ||
| Q1 24 | $25.3M | $17.1M |
| Q4 25 | $-12.0M | $9.6M | ||
| Q3 25 | $4.3M | $-19.6M | ||
| Q2 25 | $3.6M | $-13.3M | ||
| Q1 25 | $-8.3M | $-20.7M | ||
| Q4 24 | $3.3M | $-10.4M | ||
| Q3 24 | $6.7M | $-20.6M | ||
| Q2 24 | $2.8M | $-22.8M | ||
| Q1 24 | $5.9M | $-11.5M |
| Q4 25 | — | 94.8% | ||
| Q3 25 | — | 71.3% | ||
| Q2 25 | — | 86.3% | ||
| Q1 25 | — | 63.8% | ||
| Q4 24 | — | 83.0% | ||
| Q3 24 | — | 66.4% | ||
| Q2 24 | — | 56.6% | ||
| Q1 24 | — | 71.6% |
| Q4 25 | -71.9% | 27.1% | ||
| Q3 25 | 21.9% | -220.3% | ||
| Q2 25 | 19.9% | -83.9% | ||
| Q1 25 | -49.2% | -271.6% | ||
| Q4 24 | 19.9% | -34.2% | ||
| Q3 24 | 35.7% | -129.0% | ||
| Q2 24 | 19.5% | -284.9% | ||
| Q1 24 | 33.0% | -69.6% |
| Q4 25 | -49.7% | 24.7% | ||
| Q3 25 | 16.1% | -228.1% | ||
| Q2 25 | 14.2% | -86.6% | ||
| Q1 25 | -35.0% | -274.3% | ||
| Q4 24 | 14.1% | -48.4% | ||
| Q3 24 | 25.5% | -160.8% | ||
| Q2 24 | 13.8% | -285.2% | ||
| Q1 24 | 23.2% | -67.4% |
| Q4 25 | $-0.73 | $0.13 | ||
| Q3 25 | $0.22 | $-0.22 | ||
| Q2 25 | $0.18 | $-0.16 | ||
| Q1 25 | $-0.51 | $-0.25 | ||
| Q4 24 | $0.17 | $-0.12 | ||
| Q3 24 | $0.36 | $-0.29 | ||
| Q2 24 | $0.14 | $-0.32 | ||
| Q1 24 | $0.32 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $78.2M |
| Total DebtLower is stronger | — | $40.1M |
| Stockholders' EquityBook value | $304.3M | $50.5M |
| Total Assets | $3.3B | $147.8M |
| Debt / EquityLower = less leverage | — | 0.79× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $78.2M | ||
| Q3 25 | — | $58.7M | ||
| Q2 25 | — | $66.3M | ||
| Q1 25 | — | $59.8M | ||
| Q4 24 | — | $73.5M | ||
| Q3 24 | — | $90.3M | ||
| Q2 24 | — | $73.2M | ||
| Q1 24 | — | $85.5M |
| Q4 25 | — | $40.1M | ||
| Q3 25 | — | $39.7M | ||
| Q2 25 | — | $39.4M | ||
| Q1 25 | — | $29.2M | ||
| Q4 24 | — | $28.9M | ||
| Q3 24 | — | $28.6M | ||
| Q2 24 | — | $28.4M | ||
| Q1 24 | — | $28.1M |
| Q4 25 | $304.3M | $50.5M | ||
| Q3 25 | $318.5M | $38.5M | ||
| Q2 25 | $315.7M | $55.6M | ||
| Q1 25 | $314.7M | $49.6M | ||
| Q4 24 | $323.9M | $66.9M | ||
| Q3 24 | $328.1M | $73.4M | ||
| Q2 24 | $320.7M | $61.4M | ||
| Q1 24 | $320.1M | $79.3M |
| Q4 25 | $3.3B | $147.8M | ||
| Q3 25 | $3.4B | $124.0M | ||
| Q2 25 | $3.4B | $138.2M | ||
| Q1 25 | $3.5B | $128.9M | ||
| Q4 24 | $3.6B | $149.0M | ||
| Q3 24 | $3.6B | $148.2M | ||
| Q2 24 | $3.8B | $132.0M | ||
| Q1 24 | $3.8B | $149.6M |
| Q4 25 | — | 0.79× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.46× | ||
| Q1 24 | — | 0.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.9M | $20.1M |
| Free Cash FlowOCF − Capex | $34.9M | $19.6M |
| FCF MarginFCF / Revenue | 133.3% | 50.3% |
| Capex IntensityCapex / Revenue | 4.0% | 1.3% |
| Cash ConversionOCF / Net Profit | — | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | $58.2M | $-23.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.9M | $20.1M | ||
| Q3 25 | $8.7M | $-7.7M | ||
| Q2 25 | $10.3M | $-18.0M | ||
| Q1 25 | $5.0M | $-13.8M | ||
| Q4 24 | $67.7M | $-16.5M | ||
| Q3 24 | $43.5M | $-13.0M | ||
| Q2 24 | $8.1M | $-12.2M | ||
| Q1 24 | $8.3M | $-7.8M |
| Q4 25 | $34.9M | $19.6M | ||
| Q3 25 | $8.5M | $-7.9M | ||
| Q2 25 | $10.2M | $-20.5M | ||
| Q1 25 | $4.7M | $-15.1M | ||
| Q4 24 | $66.5M | $-18.2M | ||
| Q3 24 | $43.4M | $-14.0M | ||
| Q2 24 | $8.1M | $-12.6M | ||
| Q1 24 | $8.1M | $-8.9M |
| Q4 25 | 133.3% | 50.3% | ||
| Q3 25 | 32.0% | -91.7% | ||
| Q2 25 | 40.4% | -133.6% | ||
| Q1 25 | 19.8% | -199.6% | ||
| Q4 24 | 287.5% | -85.0% | ||
| Q3 24 | 166.0% | -109.0% | ||
| Q2 24 | 39.6% | -157.5% | ||
| Q1 24 | 32.3% | -52.2% |
| Q4 25 | 4.0% | 1.3% | ||
| Q3 25 | 1.1% | 2.1% | ||
| Q2 25 | 0.6% | 16.4% | ||
| Q1 25 | 1.2% | 16.7% | ||
| Q4 24 | 5.3% | 8.3% | ||
| Q3 24 | 0.3% | 7.8% | ||
| Q2 24 | 0.2% | 5.0% | ||
| Q1 24 | 0.6% | 6.6% |
| Q4 25 | — | 2.09× | ||
| Q3 25 | 2.05× | — | ||
| Q2 25 | 2.90× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 20.70× | — | ||
| Q3 24 | 6.53× | — | ||
| Q2 24 | 2.88× | — | ||
| Q1 24 | 1.41× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
